Volume depletion in adults
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
hemorrhagic losses
intravenous isotonic crystalloid
Initial choice for volume expansion.
In clinically stable patients with no evidence of active bleeding, replacement of lost plasma with crystalloid can be done while monitoring to verify no further significant drop in hematocrit.
The goal of fluid replacement is to restore hemodynamic stability and avoid shock and organ ischemia. Fluid may be delivered as rapidly infused boluses of 250 to 500 mL, repeated as necessary.[55]National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. May 2017 [internet publication]. https://www.nice.org.uk/guidance/CG174 As it is extremely difficult to estimate the true volume deficit accurately, frequent monitoring of vital signs (particularly systolic blood pressure) is used to determine when adequate fluid replacement has been administered.
packed red blood cells
Treatment recommended for ALL patients in selected patient group
Blood is the definitive intravascular volume expander, and is particularly important in the setting of anemia from acute blood loss.[29]Rossaint R, Afshari A, Bouillon B, et al. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care. 2023 Mar 1;27(1):80. https://pmc.ncbi.nlm.nih.gov/articles/PMC9977110 http://www.ncbi.nlm.nih.gov/pubmed/36859355?tool=bestpractice.com Local major hemorrhage protocols should be consulted.
Without ongoing blood loss, 1 unit of blood raises the hemoglobin concentration in the average adult by 1 g/dL.[65]Charache S, Ness PM. Transfusion therapy. In: Stobo JD, Hellmann DB, Ladenson PW, et al, eds. The principles and practice of medicine. 23rd ed. New York, NY: McGraw-Hill Professional; 1996:761-8.
fresh frozen plasma
Treatment recommended for SOME patients in selected patient group
Fresh frozen plasma (FFP) contains physiological amounts of active plasma proteins.
It is used in settings of coagulopathy or factor deficiency to replace missing clotting factors and achieve hemostasis.
In massively transfused patients, the concentration of clotting factors is decreased because much of the patient's blood volume has been replaced by transfused blood.[66]Hellstern P, Muntean W, Schramm W, et al. Practical guidelines for the clinical use of plasma. Thromb Res. 2002 Oct 31;107 Suppl 1:S53-7. http://www.ncbi.nlm.nih.gov/pubmed/12379294?tool=bestpractice.com The exact red blood cell to fresh frozen plasma ratio is still unclear.[67]Cable CA, Razavi SA, Roback JD, et al. RBC Transfusion strategies in the ICU: a concise review. Crit Care Med. 2019 Nov;47(11):1637-44. https://pmc.ncbi.nlm.nih.gov/articles/PMC8319734 http://www.ncbi.nlm.nih.gov/pubmed/31449062?tool=bestpractice.com
treatment of source of bleeding
Treatment recommended for SOME patients in selected patient group
When volume depletion due to hemorrhage is mild, typically the etiology is self-limiting and does not require intervention to stop the bleeding.
However, consideration should be given to treatment of any underlying or contributory factors, to prevent further episodes.
The role of volume expansion in acute hemorrhage is to stabilize the patient while efforts are made to identify and treat the bleeding source.
In gastrointestinal (GI) bleeding, an endoscopy is generally necessary for diagnosis and treatment. In an upper GI bleed, such as from a gastric ulcer, esophagogastroduodenoscopy provides an opportunity to examine the stomach and to intervene if bleeding has not stopped. In a lower GI bleed, such as a diverticular bleed, a colonoscopy is indicated.
In trauma or a possible bleeding aortic aneurysm, with suspected intra-abdominal or retroperitoneal bleeding, CT scanning followed by laparotomy or other surgical intervention may be necessary to identify and stop the hemorrhage.
gastrointestinal nonhemorrhagic losses: vomiting and/or diarrhea
oral replacement solutions
In cases of mild volume depletion (e.g., if there are minimal symptoms on standing; no orthostatic hypotension; no signs of systemic hypoperfusion; tachycardia; and vomiting and diarrhea are absent or controllable), treatment with oral replacement solutions can be attempted initially.
Sodium chloride tablets and electrolyte-containing solutions can be used. Glucose is typically added to these oral replacement solutions to promote uptake of sodium via the intestinal sodium/glucose co-transporter mechanism.
Solutions that are rice-based are effective in cholera, given the absorption of both protein and glucose that occurs with rice digestion.[9]Alam NH, Majumder RM, Fuchs GJ. Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double-blind clinical trial. Lancet. 1999 Jul 24;354(9175):296-9. http://www.ncbi.nlm.nih.gov/pubmed/10440307?tool=bestpractice.com
Oral solutions are the treatment of choice in developing countries for diarrheal illnesses due to the lack of access to intravenous therapy.
Pediatric electrolyte solutions are used in children, particularly with gastroenteritis. These products contain sodium, potassium, chloride, citrate, and dextrose, and are designed to replace the solute and water that is lost with vomiting or diarrhea.[54]Kellum JA. Acute kidney injury. Crit Care Med. 2008 Apr;36(4 Suppl):S141-5. http://www.ncbi.nlm.nih.gov/pubmed/18382185?tool=bestpractice.com
intravenous isotonic crystalloid
Treatment recommended for SOME patients in selected patient group
Isotonic crystalloid is the best initial choice for volume expansion.
If symptoms and vital signs do not respond adequately to oral replacement or the patient cannot tolerate oral replacement due to persistent vomiting, intravenous replacement is necessary.
Certain patient groups (e.g., young adults) may be able to compensate well and so initially appear only mildly volume-depleted. However, they may, in fact, have more deficit than clinically estimated.
Most patients will respond quickly to intravenous fluid resuscitation in this setting.
If there is continued nausea and vomiting on presentation despite only mild signs of volume depletion, intravenous saline is the most appropriate initial choice for resuscitation.
antiemetics or antidiarrheals
Treatment recommended for SOME patients in selected patient group
Promethazine, dosed orally or rectally, can be given for nausea and vomiting.
Oral metoclopramide may also be used. Metoclopramide should be used for up to 5 days only, in order to minimize the risk of neurologic and other adverse effects.[68]European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. July 2013 [internet publication]. https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-changes-use-metoclopramide
Orally administered ondansetron is also suitable in this setting.
Intravenous promethazine, ondansetron, or related drugs can be used in the emergency department, or in cases of continued vomiting.
Antidiarrheals, such as diphenoxylate/atropine or loperamide, can be given in cases of noninfectious diarrhea.
Primary options
promethazine: 25 mg orally/rectally/intravenously every 6-8 hours when required
OR
metoclopramide: 5-10 mg orally every 8 hours when required for a maximum of 5 days, maximum 30 mg/day
OR
ondansetron: 8 mg orally/intravenously every 8 hours when required
OR
diphenoxylate/atropine: 2.5 to 5 mg orally two to four times daily when required, maximum 20 mg/day
More diphenoxylate/atropineDose refers to diphenoxylate component.
OR
loperamide: 4 mg orally initially, followed by 2 mg orally after each loose stool when required, maximum 16 mg/day
intravenous isotonic crystalloid for initial volume resuscitation
In moderate to severe cases of volume depletion (e.g., orthostatic hypotension is usually present with hemodynamic instability and there may be signs of systemic hypoperfusion and organ ischemia), oral replacement solutions are not adequate to replace lost volume.
These patients often require hospitalization for monitoring during resuscitation, or at least close and protracted monitoring in an emergency department setting.
Liters of fluid may be required, but stabilization is usually easily achieved in these patients.
intravenous hypotonic saline (0.45% sodium chloride)
Treatment recommended for SOME patients in selected patient group
Once the initial volume deficit is replaced with isotonic crystalloid, 0.45% sodium chloride is often used as a maintenance fluid.
Hypotonic saline has a concentration of 77 mEq sodium per liter, and can be used when there is hypernatremia and a water deficit greater than the solute deficit.
If the patient is severely hypernatremic (>160 mEq/L) and volume-depleted, isotonic crystalloid may still be preferred initially because the volume deficit is more immediately life-threatening.[5]Rose BD, Post TW. Hypovolemic states. In: Clinical physiology of acid-base and electrolyte disorders. 5th ed. New York, NY: McGraw-Hill; 2001:415-46.[11]Portilla D, Andreoli TE. Disorders of extracellular volume. In: Johnson RJ, Feehally J, eds. Comprehensive clinical nephrology. London: Mosby International; 2007:77-91.
antiemetics
Treatment recommended for SOME patients in selected patient group
Intravenous promethazine, metoclopramide, or ondansetron are very helpful in this situation. Metoclopramide should be used for up to 5 days only, in order to minimize the risk of neurologic and other adverse effects.[68]European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. July 2013 [internet publication]. https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-changes-use-metoclopramide
Primary options
promethazine: 25 mg intravenously every 6-8 hours when required
OR
metoclopramide: 5-10 mg intravenously/intramuscularly every 8 hours when required for a maximum of 5 days, maximum 30 mg/day
OR
ondansetron: 8 mg intravenously every 8 hours when required
intravenous isotonic sodium bicarbonate
Treatment recommended for SOME patients in selected patient group
An argument can be made for the use of sodium bicarbonate in settings of volume depletion and metabolic acidosis. However, without knowledge of the lab results, intravenous isotonic crystalloid is still the preferred initial choice for volume resuscitation.
The use of bicarbonate in anion gap acidosis such as lactic acidosis has been challenged, as its administration could increase intracellular acidosis and lactate production, and impair tissue oxygen delivery.[69]Cooper DJ, Walley KR, Wiggs BR, et al. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med. 1990 Apr 1;112(7):492-8. http://www.ncbi.nlm.nih.gov/pubmed/2156475?tool=bestpractice.com
Repeated administration of hypertonic ampoules will lead to hypernatremia, a problem that can be avoided by using an isotonic sodium bicarbonate infusion.
intravenous vasopressors
Treatment recommended for SOME patients in selected patient group
In general, intravenous vasopressors are not indicated in shock due to gastrointestinal losses, as saline resuscitation is the appropriate treatment. However, if sepsis is suspected, vasopressors may be necessary. A mean arterial pressure of ≥65 mmHg is the recommended target in patients with septic shock on vasopressors.[27]Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181-247. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486643 http://www.ncbi.nlm.nih.gov/pubmed/34599691?tool=bestpractice.com
Primary options
norepinephrine: 0.02 to 3.3 micrograms/kg/minute intravenously, titrate according to response, maximum 30 micrograms/kg/minute
intravenous lactated Ringer solution
Lactated Ringer solution contains 130 mEq/L sodium, 28 mEq/L lactate, 4 mEq/L potassium, as well as calcium and chloride, and can expand the intravascular space, but generally isotonic saline is preferred.
Lactate is converted to bicarbonate, which can be helpful in metabolic acidosis, but in lactic acidosis and liver disease this conversion is impaired, so lactate-containing fluids should be avoided in these circumstances.
In renal failure, the use of lactated Ringer solution can contribute to hyperkalemia.[5]Rose BD, Post TW. Hypovolemic states. In: Clinical physiology of acid-base and electrolyte disorders. 5th ed. New York, NY: McGraw-Hill; 2001:415-46.
antiemetics
Treatment recommended for SOME patients in selected patient group
Intravenous promethazine, metoclopramide, or ondansetron are very helpful in this situation. Metoclopramide should be used for up to 5 days only, in order to minimize the risk of neurologic and other adverse effects.[68]European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. July 2013 [internet publication]. https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-changes-use-metoclopramide
Primary options
promethazine: 25 mg intravenously every 6-8 hours when required
OR
metoclopramide: 5-10 mg intravenously/intramuscularly every 8 hours when required for a maximum of 5 days, maximum 30 mg/day
OR
ondansetron: 8 mg intravenously every 8 hours when required
intravenous isotonic sodium bicarbonate
Treatment recommended for SOME patients in selected patient group
An argument can be made for the use of sodium bicarbonate in settings of volume depletion and metabolic acidosis. However, without knowledge of the lab results, intravenous isotonic crystalloid is still the preferred initial choice for volume resuscitation.
The use of bicarbonate in anion gap acidosis such as lactic acidosis is controversial, as its administration can increase intracellular acidosis and lactate production, and impair tissue oxygen delivery.[69]Cooper DJ, Walley KR, Wiggs BR, et al. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med. 1990 Apr 1;112(7):492-8. http://www.ncbi.nlm.nih.gov/pubmed/2156475?tool=bestpractice.com
Repeated administration of hypertonic ampoules will lead to hypernatremia, a problem that can be avoided by using an isotonic sodium bicarbonate infusion.
intravenous vasopressors
Treatment recommended for SOME patients in selected patient group
In general, intravenous vasopressors are not indicated in shock due to gastrointestinal losses, as saline resuscitation is the appropriate treatment. However, if sepsis is suspected, vasopressors may be necessary. A mean arterial pressure of ≥65 mmHg is the recommended target in patients with septic shock on vasopressors.[27]Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181-247. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486643 http://www.ncbi.nlm.nih.gov/pubmed/34599691?tool=bestpractice.com
Primary options
norepinephrine: 0.02 to 3.3 micrograms/kg/minute intravenously, titrate according to response, maximum 30 micrograms/kg/minute
excessive diuresis
assessment for withholding of any diuretics
Consideration should be made for modification or withholding of any diuretics being used.
oral replacement solutions
Treatment recommended for ALL patients in selected patient group
Oral replacement is appropriate if it is possible to maintain oral intake to match the renal losses without a resulting electrolyte abnormality or hemodynamic instability.
Sodium chloride tablets and electrolyte-containing solutions can be used. Glucose is typically added to these oral replacement solutions to promote uptake of sodium via the intestinal sodium/glucose co-transporter mechanism.
intravenous fluids
Treatment recommended for SOME patients in selected patient group
Isotonic crystalloid is the best initial choice for volume expansion when needed.
In addition to overuse of diuretics, osmotic diuresis is also caused by glycosuria due to uncontrolled diabetes; by adrenal insufficiency; or rarely by salt-wasting nephropathies.
Renal water excretion can be severe in the setting of diabetes insipidus, but this primarily causes dehydration and hypernatremia.[1]Mange K, Matsuura D, Cizman B, et al. Language guiding therapy: the case of dehydration versus volume depletion. Ann Intern Med. 1997 Nov 1;127(9):848-53. http://www.ncbi.nlm.nih.gov/pubmed/9382413?tool=bestpractice.com [5]Rose BD, Post TW. Hypovolemic states. In: Clinical physiology of acid-base and electrolyte disorders. 5th ed. New York, NY: McGraw-Hill; 2001:415-46.[10]Uribarri J, Oh MS, Carroll HJ. Salt-losing nephropathy: clinical presentation and mechanisms. Am J Nephrol. 1983 Jul-Aug;3(4):193-8. http://www.ncbi.nlm.nih.gov/pubmed/6351615?tool=bestpractice.com [11]Portilla D, Andreoli TE. Disorders of extracellular volume. In: Johnson RJ, Feehally J, eds. Comprehensive clinical nephrology. London: Mosby International; 2007:77-91.
The type of crystalloid solution required will depend on the electrolyte abnormalities detected by laboratory testing. Generally, isotonic crystalloid is the first line. However, if significant hypernatremia is present, 0.45% normal saline may be appropriate to replace the water deficit as well. As dehydration and volume depletion may occur together, 0.45% saline allows for replacement of both solute and free water loss.
skin losses
intravenous isotonic crystalloid
Isotonic crystalloid will best replace the fluid that is lost through burned skin.
The volume deficit can be many liters in severe burns covering a large surface area. The Parkland formula aims to calculate the fluid resuscitation requirement in the first 24 hours, using the formula (4 mL x bodyweight in kg x % total body surface area burn) with half the calculated volume given in the first 8 hours and the other half given over the remaining 16 hours. However, close attention should also be given to monitoring urine output per hour and resuscitation adjusted accordingly to maintain an output of 0.5 to 1 mL/kg/hr.
Close monitoring of vital signs is necessary, however, given the potential for over-resuscitation in burn patients. Too much fluid can lead to increased intra-abdominal pressure and compartment syndromes.[61]Ipaktchi K, Arbabi S. Advances in burn critical care. Crit Care Med. 2006 Sep;34(9 Suppl):S239-44. http://www.ncbi.nlm.nih.gov/pubmed/16917429?tool=bestpractice.com The American Burn Association clinicians advises to provide albumin in the first 24 hours of burn resuscitation to improve urinary output and to reduce the total volume of resuscitation fluids.[62]Cartotto R, Johnson LS, Savetamal A, et al. American burn association clinical practice guidelines on burn shock resuscitation. J Burn Care Res. 2024 May 6;45(3):565-89. https://academic.oup.com/jbcr/article/45/3/565/7458089 http://www.ncbi.nlm.nih.gov/pubmed/38051821?tool=bestpractice.com The strength of this recommendation is greater for patients with larger burns, and weaker for patients with smaller burns.[62]Cartotto R, Johnson LS, Savetamal A, et al. American burn association clinical practice guidelines on burn shock resuscitation. J Burn Care Res. 2024 May 6;45(3):565-89. https://academic.oup.com/jbcr/article/45/3/565/7458089 http://www.ncbi.nlm.nih.gov/pubmed/38051821?tool=bestpractice.com Administration of albumin in “rescue” situations may be considered where resuscitation is deteriorating despite receiving escalating amounts of crystalloids.[62]Cartotto R, Johnson LS, Savetamal A, et al. American burn association clinical practice guidelines on burn shock resuscitation. J Burn Care Res. 2024 May 6;45(3):565-89. https://academic.oup.com/jbcr/article/45/3/565/7458089 http://www.ncbi.nlm.nih.gov/pubmed/38051821?tool=bestpractice.com
treatment of burns: artificial skin or allografts
Treatment recommended for ALL patients in selected patient group
Referral to a specialist burn center is necessary if the burn is severe and covers a large surface area but local resources and practice patterns should be taken into account. There, definitive treatment such as debridement, wound dressing, and antibiotics will be used as indicated.
Ultimately skin grafts can be done to cover damaged areas with exposed tissue for cosmetic purposes and functional outcome, as well as to limit the potential for continued fluid loss.[63]American Burn Association. Advanced burn life support course. Chicago, IL: American Burn Association; 2018.
oral replacement solutions or intravenous fluids
When there has been excessive sweating but systolic blood pressure (SBP) remains >100 mmHg and pulse <100 bpm, it is reasonable to use oral replacement solutions or intravenous 0.45% sodium chloride. Sweat contains less solute than the fluid lost through burns, and, therefore, in less severe cases the deficit can be replaced with a hypotonic solution.
However, in more severe situations, with SBP <100 mmHg and/or pulse >100 bpm, isotonic crystalloid is the preferred initial choice; hypotonic saline or oral replacement solutions can then be used once the vital signs improve and patients are hemodynamically stable. When volume loss from excessive sweating is severe and leads to hypotension (SBP <100 mmHg) with symptoms such as confusion, isotonic saline should be used.
As in other states of moderate to severe volume depletion, the best choice is the fluid that will expand the intravascular space.
Even if there is a component of hypernatremia from dehydration, when volume depletion exists, isotonic saline should be used.
It is rare to see severe volume depletion and hypotension from sweating alone.
third-space sequestration
intravenous isotonic saline
Third-space sequestration refers to abnormal collections of fluid developing in spaces where they cannot be reabsorbed into the intravascular space. Examples include ascites due to cirrhosis or Budd-Chiari syndrome, venous obstruction, severe pancreatitis, crush injury (fluid in damaged or devitalized muscle) and intestinal obstruction.[5]Rose BD, Post TW. Hypovolemic states. In: Clinical physiology of acid-base and electrolyte disorders. 5th ed. New York, NY: McGraw-Hill; 2001:415-46.[11]Portilla D, Andreoli TE. Disorders of extracellular volume. In: Johnson RJ, Feehally J, eds. Comprehensive clinical nephrology. London: Mosby International; 2007:77-91. Clinical judgment should determine whether a patient has fluid losses into the third space since the concept of a loss of extracellular fluid to the third space is controversial.[64]Voldby AW, Brandstrup B. Fluid therapy in the perioperative setting-a clinical review. J Intensive Care. 2016;4:27. https://pmc.ncbi.nlm.nih.gov/articles/PMC4833950 http://www.ncbi.nlm.nih.gov/pubmed/27087980?tool=bestpractice.com
The fluid is sequestered from the intravascular space causing symptoms of volume depletion, so the resuscitation is an attempt to increase intravascular volume, and isotonic saline is the best choice.
Close monitoring of vital signs and response to resuscitation is important, as the deficit in third-space sequestration can be many liters. Care must be undertaken in certain situations, such as cirrhosis, when too much fluid can be detrimental. See Cirrhosis.
management of underlying condition
Treatment recommended for ALL patients in selected patient group
Conservative management for bowel obstruction with nasogastric decompression is often initially attempted. However, in some patients, a surgical intervention is required to relieve the obstruction.
Obstruction of a large vein, such as the portal vein, can lead to ascites and fluid sequestration that may be difficult to manage. In some settings of venous obstruction, anticoagulants are used and the volume deficit replaced appropriately while waiting for response to anticoagulation. Diuretics and albumin may be used in cirrhotic ascites.
Orthopedic consultation for measurement of compartment pressures and fasciotomy, if indicated, should be considered for crush injury.
pulmonary losses: bronchorrhea or draining pleural effusion
intravenous isotonic saline
Bronchorrhea (i.e., excessive discharge of mucus from the bronchi) or draining pleural effusion are rare causes for volume depletion, but may be seen in chronically ill or hospitalized patients.
Symptoms are a reflection of intravascular volume depletion, so the intravascular space must be expanded with isotonic solution.
treatment of underlying condition
Treatment recommended for ALL patients in selected patient group
Pleurodesis may be necessary to limit continued drainage into the pleural space.
If bronchorrhea is severe enough to lead to volume loss, appropriate treatment of the infection is necessary.
sustained inadequate oral intake
oral rehydration solutions
The inadequate oral intake must be recognized and vital signs and symptoms of volume depletion monitored closely.
This is generally seen in infants and in older people with limited ability to communicate thirst.
Sodium chloride tablets and electrolyte-containing solutions can be used. Glucose is typically added to oral replacement solutions to promote uptake of sodium via the intestinal sodium/glucose co-transporter mechanism.
intravenous fluids
Treatment recommended for SOME patients in selected patient group
Isotonic crystalloid is the best initial choice for volume expansion.
The goal of fluid replacement is to restore hemodynamic stability and avoid shock and organ ischemia. Fluid is typically delivered as boluses of 250 to 500 mL of crystalloid, repeated as necessary. As it is extremely difficult to estimate the true volume deficit accurately, frequent monitoring of vital signs (particularly systolic blood pressure) is used to determine when adequate fluid replacement has been administered.
Once the volume deficit is replenished with isotonic saline, 0.45% normal saline can be used as a maintenance fluid.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer